Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPMATINIB vs CAPTOPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPMATINIB vs CAPTOPRIL: Safety Overview

Metric CAPMATINIB CAPTOPRIL
Total FAERS Reports 2,301 1,126
Deaths Reported 583 108
Death Rate 25.3% 9.6%
Hospitalizations 388 615
Average Patient Age 71.9 yrs 56.1 yrs
% Female Patients 53.9% 60.9%
FDA Approval Date May 6, 2020 Approved Prior to Jan 1, 1982
Manufacturer Novartis Pharmaceuticals Corporation Bryant Ranch Prepack
Route ORAL ORAL
Marketing Status Prescription Discontinued